Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FQSV6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The award, issued on December 16, 2025, contains no set-aside designation and requires ultimate completion by January 8, 2026, with performance to be fulfilled at the vendor's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical pharmaceutical supplier within the federal military medical supply chain, with consistent performance across numerous delivery orders spanning oncology treatments, biologics, vaccines, and specialty pharmaceuticals issued primarily between October and December 2025. The company's PPV-G GEN V contract, valued at up to $499,999,999 and extending through December 31, 2036, positions it as one of multiple regional prime vendor contractors serving DoD healthcare facilities worldwide. No subcontractors are identified on this award, with DMS Pharmaceutical Group providing direct supply of the pharmaceutical products requested by the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FQSV6?
SPE2DR26FQSV6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FQSV6 worth?
The government has obligated $16,584 on SPE2DR26FQSV6.
Is contract SPE2DR26FQSV6 an order under another contract?
Yes. SPE2DR26FQSV6 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQSV6 competed?
The extent of competition for SPE2DR26FQSV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award